Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Humacyte (HUMA) Interest Expenses (2024 - 2025)

Humacyte has reported Interest Expenses over the past 2 years, most recently at $3.1 million for Q4 2025.

  • Quarterly results put Interest Expenses at $3.1 million for Q4 2025, up 23.33% from a year ago — trailing twelve months through Dec 2025 was $11.2 million (up 21.27% YoY), and the annual figure for FY2025 was $11.2 million, up 21.27%.
  • Interest Expenses for Q4 2025 was $3.1 million at Humacyte, up from $2.6 million in the prior quarter.
  • Over the last five years, Interest Expenses for HUMA hit a ceiling of $3.1 million in Q4 2025 and a floor of $1.8 million in Q1 2024.